RecruitingPhase 3NCT07174310
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Sponsor: Hoffmann-La Roche
Amherst, NY · Commack, NY · New York, NY · +50 more sites
3 recruiting parkinson's disease studies with a site in Commack, NY.
Sponsor: Hoffmann-La Roche
Amherst, NY · Commack, NY · New York, NY · +50 more sites
Sponsor: Supernus Pharmaceuticals, Inc.
Commack, NY · +4 more sites
Sponsor: Impax Laboratories, LLC
Commack, NY · +26 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.